INTELLIGENCE ENGINE ACTIVE
Loading market intelligence...
Synchronizing institutional flows, real-time analytics & intelligence models
Market Wisdom & Tenets
Value Investing“Price is what you pay. Value is what you get.”
Warren Buffett
+10
🤖 Claude MCP on paid plans — NSE/BSE data, screeners & research in Claude Desktop & Claude Code.
✨ Setup guideConnecting to market data…
Synchronizing institutional flows, real-time analytics & intelligence models
“Price is what you pay. Value is what you get.”
Aggregating institutional notes, consensus estimates & financial filings
“Price is what you pay. Value is what you get.”
Live intelligence from Upstox & official NSE regulatory filings (XBRL), with Yahoo / SEC fallbacks for US names.
GLAND PHARMA LIMITED
₹3,334.10
Market closed · as of 00:55 IST · 14-11-2026
0 intraday points
Low
₹3,307.20
High
₹3,355.00
₹3,308.70
Previous close — your comparison point.
Up 0.77% from the previous close.
Data: Upstox
← Research home · Updated 11/13/2026, 7:25:04 PM
Checking what moves GLAND…
Business description (company filings, via Screener)
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
Source: Screener.inReading filings for GLAND…